The incidence of bladder cancer (BC) is increasing, and although current therapeutic approaches are effective in many cases, recurrence of BC is common. Therefore, it seems necessary to search not only for novel therapeutic approaches, but also for new therapeutic agents. Natural polyphenols, such as curcumin (CUR) and epigallocatechin gallate (EGCG), possess remarkable antitumor activity. Their biochemical mechanisms of action include regulation of signaling pathways, modeling of proteins involved in apoptosis and cell cycle inhibition, angiogenesis, and the proliferation, migration and adhesion of tumor cells. Both compounds also present antioxidant, anti-inflammatory, antibacterial and antiviral properties. CUR has been considered a promising candidate for the treatment of cystic fibrosis, Alzheimer’s disease or malaria, whereas EGCG can play a supportive role in the treatment of obesity, metabolic and neurodegenerative diseases. The review summarizes the latest research on the role of CUR and EGCG in the treatment of BC. In particular, the effects of CUR and EGCG, and their prospects for use in BC therapy, their inhibition of cancer development and their prevention of multidrug resistance, are described. The literature’s data indicate the possibility of achieving the effect of synergism of both polyphenols in BC therapy, which has been observed so far in the treatment of ovarian, breast and prostate cancer.
Choline salicylate (CS) as a derivative of acetylsalicylic acid is commonly used in different drug forms. In medicine, it is applied topically to inflammation of the oral cavity mucosa and in laryngology. However, this substance in the form of an ionic liquid has not been investigated enough. There are no literature studies on stability tests constituting a stage of pre-formulation research. HPLC (Nucleosil C18, 4.6 × 150 mm, 5 μm; methanol-water-acetic acid 60:40:1, 230 nm or 270 nm) and UV (276 nm) methods for the determination of CS in 2% (g/mL) aqueous solutions were developed. Under stress conditions, CS susceptibility to hydrolytic degradation in aqueous medium, hydrochloric acid, sodium hydroxide, and hydrogen peroxide, and the effect of light on the stability of CS solutions were studied with HPLC analysis. The degradation degree of CS and the purity of the solutions were also tested. Choline salicylate has been qualified as practically stable in neutral and acid media, stable in an alkaline medium, very stable in an oxidizing environment, and photolabile in solution. The HPLC-MS/MS method was used to identify 2,3- and 2,5-dihydroxybenzoic acids as degradation products of CS under the tested conditions.
Background:
Tuberculosis (TB) has been present in the history of human civilization
since time immemorial and has caused more deaths than any other infectious disease. It is still considered
one of the ten most common epidemiologic causes of death in the world. As a transmissible
disease, it is initiated by rod-shaped (bacillus) mycobacteria. The management of tuberculosis became
possible owing to several discoveries beginning in 1882 with the isolation of the TB bacillus
by Robert Koch. The diagnosis of TB was enabled by finding a staining method for TB bacteria
identification (1883). It was soon realized that a large-scale policy for the treatment and prevention
of tuberculosis was necessary, which resulted in the foundation of International Union against Tuberculosis
and Lung Diseases (1902). An antituberculosis vaccine was developed in 1921 and has
been in therapeutic use since then. TB treatment regimens have changed over the decades and the
latest recommendations are known as Directly Observed Treatment Short-course (DOTS, WHO
1993).
Methods:
A search of bibliographic databases was performed for peer-reviewed research literature.
A focused review question and inclusion criteria were applied. Standard tools were used to assess
the quality of retrieved papers.
Results:
A total of 112 papers were included comprising original publications and reviews. The
paper overviews anti-TB drugs according to their mechanism of action. The chemical structure,
metabolism and unwanted effects of such drugs have been discussed. The most recent treatment
regimens and new drugs, including those in clinical trials, are also presented.
Conclusion:
Despite a 22% decrease in the tuberculosis fatality rate observed between 2000 and
2015, the disease remains one of the ten prime causes of death worldwide. Increasing bacterial resistance
and expensive, prolonged therapies are the main reasons for efforts to find effective drugs or
antituberculosis regimens, especially to cure multidrug-resistant tuberculosis.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.